Actively Recruiting
Phase 2 Study Comparing Pulsed Low-Dose-Rate Radiation Chemoradiation Versus Standard Chemoradiation for Treating Locally Advanced Esophageal Cancer
Led by Medical College of Wisconsin · Updated on 2026-07-28
50
Participants Needed
1
Research Sites
82 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new radiation technique called Pulsed Low-Dose-Rate PLDR radiation combined with chemotherapy for treating locally advanced esophageal cancer. This phase 2 trial compares PLDR chemoradiation against standard chemoradiation to see if PLDR reduces the rates of clinically significant esophagitis, a side effect affecting the esophagus during and after treatment. Participants receive induction chemotherapy for 2 to 4 months, typically with modified FLOT or FOLFOX-6 regimens, followed by concurrent chemoradiation. In the experimental group, radiation is delivered in low-dose pulses separated by timed pauses, while the control group receives standard continuous radiation. Both groups receive the same total radiation dose and chemotherapy, mainly carboplatin and paclitaxel weekly. Surgery esophagectomy may be performed 6 to 13 weeks after chemoradiation based on medical judgment but is not required by the trial. During the study, participants are closely monitored for side effects including narcotic use and oral intake ability up to 6 weeks after radiation. Researchers assess new or increased narcotic prescriptions and swallowing function as primary outcomes. The trial is randomized and open-label, with participants followed through treatment and recovery to understand the differences in treatment tolerability and safety. The total study duration extends through the treatment and follow-up phases until June 2032.
CONDITIONS
Brief Title
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Research Team
M
Medical College of Wisconsin Cancer Center Clinical Trials Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here